Executive Vice President, R&D, Chief Medical Officer @ Kite Pharma
Vice President of Global Development and Head of Hematology-Oncology @ Amgen
David Chang's Education
Dana-Farber Cancer Institute
Fellowship (Medical Oncology Residency Program)
1992 - 1994
Brigham and Women's Hospital
Internship and Residency (Internal Medicine Residency Program)
1990 - 1992
Massachusetts Institute of Technology
Damon-Runyon Postdoctoral Fellow (Advisor: Phillip A. Sharp, PhD)
1988 - 1990
Stanford University
MD/PhD, NIH MSTP Trainee (Advisor: David A. Clayton, PhD)
1981 - 1988
Massachusetts Institute of Technology
BS (Biology, General)
1978 - 1981
David Chang's Summary
David Chang, based in United States, is currently a President and Chief Executive Officer at Allogene Therapeutics, bringing experience from previous roles at Kite Pharma and Amgen. David Chang holds a 1992 - 1994 Fellowship in Medical Oncology Residency Program @ Dana-Farber Cancer Institute. David Chang has 1 email on RocketReach.